Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 BlockadeStacy J. Kowalsky, David L. Bartlett|Molecular Therapy|2018Cited by 141
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesZong Sheng Guo, David L. Bartlett|Frontiers in Immunology|2017Cited by 92
Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2Zuqiang Liu, David L. Bartlett|Nature Communications|2018Cited by 91
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwideChandrakanth Are, Cheng Har Yip, Murray F. Brennan et al.|The Lancet Oncology|2023Cited by 87
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safetyYan Ge, David L. Bartlett|Journal for ImmunoTherapy of Cancer|2020Cited by 78